ABSTRACT: Forensic epigenetics has become a rapidly expanding frontier in molecular forensics, offering analytical capabilities that surpass those of traditional genetic markers. Advances in ...

Intelligent Bio on Wednesday announced a new strategic manufacturing partnership with Syrma Johari MedTech Ltd. to support and scale the production of its Intelligent Fingerprinting Drug Screening ...

Rare disease drug developer BioMarin Pharmaceutical is buying its way to revenue growth with a $4.8 billion deal for Amicus Therapeutics, a company whose two commercialized products each offer ...

CHICAGO, Dec. 18, 2025 /PRNewswire/ -- Amphix Bio today announced the initial closing of a $12.5 million seed financing round to advance its lead therapeutic candidates toward human clinical trials ...

Biology exam for CBSE Class 12 is scheduled for March 27, 2026, with 33 compulsory questions The question paper has five sections with marks ranging from 1 to 5 for different question types ...

Human biology evolved for a world of movement, nature, and short bursts of stress—not the constant pressure of modern life. Industrial environments overstimulate our stress systems and erode both ...

A Russian cosmonaut was removed from the upcoming NASA and SpaceX Crew-12 mission. Russia's space agency did not give a reason, but reports suggest a national security violation. The Crew-12 mission ...

KALA BIO, Inc. (NASDAQ: KALA) shares jumped 22.16% to $1.13 in after-hours trading on Wednesday. Check out the current price of KALA stock here. Securities and Exchange Commission filings indicate ...

Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...

Artificial intelligence can do the work currently performed by nearly 12% of America's workforce, according to a recent study from the Massachusetts Institute of Technology. The researchers, relying ...

Findings establish CAR-M as a potential new immune-reset modality with improved safety over in vivo CAR-T approaches Liberate Bio, Inc., a biotechnology company developing genetic medicines that ...